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Abstract 
Background: Despite the increasing prevalence of chronic kidney disease (CKD) in sub-Saharan Africa, few com-
munity-based screenings have been conducted in Uganda. Opportunities to improve the management of CKD in 
sub-Saharan Africa are limited by low awareness, inadequate access, poor recognition, and delayed presentation for 
clinical care. Therefore, the Uganda Kidney Foundation engaged key stakeholders in performing a screening event on 
World Kidney Day.
Methods: We conducted a cross-sectional pilot study in March 2013 from a convenience sample of adult, urban 
residents in Kampala, Uganda. We advertised the event using radio and television announcements, newspapers, 
billboards, and notice boards at public places, such as places of worship. Subsequently, we screened for proteinuria, 
hypertension, fasting glucose impairment, and obesity in a central and easily-accessible location.
Results: We enrolled 141 adults most of whom were female (57 %), young (64 %; 18–39 years), and had a professional 
occupation (52 %). The prevalence of proteinuria (13 %; 95 % confidence interval [CI] 7–19 %), hypertension (38 %; 
95 % CI 31–47 %), and impaired fasting glucose (13 %; 95 % CI 9–20 %) were high in this study population. Proteinuria 
was most prevalent among young (18–39 years) adults (n = 14; 16 %) and among those who reported a history of 
alcohol intake (n = 10; 32 %).
Conclusions: The prevalence of proteinuria was high among a convenience sample of urban residents in a sub-
Saharan African setting. These results represent an important effort by the Ugandan Kidney Foundation to increase 
awareness and recognition of CKD, and they will help formulate additional epidemiological studies on NCDs in 
Uganda which are urgently needed and now feasible.
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Background
Chronic kidney disease (CKD) is a growing health bur-
den globally, with many known and unknown etiologies 
[1]. In sub-Saharan Africa (SSA), the epidemiology of 
CKD has not been well described [2], and in Uganda, few 
community-based studies assessing kidney function have 
been conducted. Nonetheless, recent epidemiological 
studies in SSA suggest that the prevalence is substantial, 
with estimates as high as 24  % in Zambia and 15  % in 
some urban areas of Tanzania [2–7].
Opportunities to improve the management of CKD 
in SSA are limited by low awareness, inadequate access, 
poor recognition, and delayed presentation for clinical 
care [8]. As such, the morbidity and mortality from CKD 
are significant especially considering the lack of cardio-
vascular care and inadequate access to renal replacement 
therapies (RRT), such as peritoneal dialysis, hemodialy-
sis, or kidney transplantation [9]. In Uganda, hemodi-
alysis services are only available in limited urban centers 
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(0.1 dialysis machine/100,000 population) and there are 
no active kidney transplant programs [9]. In 2011, kid-
ney disease was the 13th most common cause of death 
in Uganda, with the estimated annual age-adjusted death 
rate attributable to CKD in Uganda (27.8 per 100,000 
population) [10] exceeding the global estimate (16.3 per 
100,000) [1].
Given the limited understanding of kidney disease in 
Uganda, the Uganda Kidney Foundation was founded on 
March 13th 2013 to advocate, increase awareness, and 
improve care for kidney disease in Uganda. To achieve 
this mission, demonstrating the feasibility of screen-
ing studies that can describe the epidemiology of kid-
ney disease are urgently needed. Therefore, as part of 
the International Society of Nephrology World Kidney 
Day Campaign on March 13th 2013 in Kampala, we per-
formed a community-based pilot study to raise aware-




Ethical approval for this study was granted by the Mulago 
Hospital Ethical Review Board. Informed consent was 
obtained from all participants prior to their enrollment.
Study design, participants, and site
We conducted a cross-sectional pilot study in March 
2013 from a convenience sample of adult (≥18 years old) 
urban residents in Kampala, Uganda. Kampala is the larg-
est city in Uganda with a population of more than 1.5 
million people [11]. Most residents belong to the Bantu 
ethnic group, but Nilotes and other ethnicities are also 
common [12].
Prior to the study, we advertised using radio and televi-
sion announcements, newspapers, billboards, and noti-
ceboards at public places, such as places of worship. The 
advertisements were designed to produce a study catch-
ment area that included all the five divisions of Kampala 
[11]. To be eligible for the study, individuals had to be 
overnight fasting and report no prior medical history of 
kidney disease. We enrolled consecutive individuals who 
met these inclusion criteria. The study site was located on 
the campus of Makerere University College of Health Sci-
ences (MakCHS), School of Medicine, which is located 
3 km from the city center and is easily accessible.
Data collection
We collected socio-demographic characteristics from 
interviewer-administered surveys, as well as anthro-
pometric and blood pressure measurements, random 
blood glucose (RBG) using a finger-prick glucose assay, 
and a mid-stream clean-catch urine for urine protein. 
Individuals who screened positive for disease were pro-
vided appropriate referral to Mulago Hospital for further 
clinical care.
For the anthropometric measurements, weight was 
measured in kilograms (kg) using a pre-calibrated weigh-
ing scale (Seca scale). Height was measured in centimeters 
(cm) using a standardized stadiometer. Body mass index 
(BMI) was calculated from the weight and height meas-
urements for respondents as follows: BMI  =  (weight/
height2). Overweight was defined as BMI between 25 and 
30 kg/m2; obesity was defined as BMI ≥30 kg/m2.
Blood pressure was measured using automated sphyg-
momanometers that were calibrated according to the 
manufacturer’s recommendations. Blood pressure was 
measured after 10 min rest in a seated position. A second 
blood pressure measurement was taken at a minimum 
5  min interval from the initial measurement. Systolic 
hypertension was defined as an average systolic blood 
pressure (SBP) ≥140 mmHg, and diastolic hypertension 
was defined as an average diastolic blood pressure (DBP) 
≥90  mmHg. Hypertension was defined as the presence 
of systolic or diastolic hypertension, or on-going use of 
blood pressure lowering medicines among those with 
self-reported history of hypertension.
Finger-prick blood samples were obtained to meas-
ure random blood glucose using the Accu-Chek Active 
glucometer (Roche Diagnostics, Germany), which was 
calibrated according to the manufacturer’s recommen-
dation. Fasting glucose impairment was defined as RBG 
>126  mg/dl, or on-going use of anti-diabetic medicines 
among those who reported having diabetes. Respondents 
also provided a clean-catch midstream urine specimen 
in sterile containers for a dipstick urinalysis (Combur 
Test M, Roche Diagnostics, Germany). Proteinuria was 
defined as a urine protein of ≥1+ on dipstick in the 
absence of hematuria and leukocyturia.
Statistical analysis
Data were manually entered into a Microsoft Excel 
spreadsheet. All entries were double-checked for accu-
racy by two independent study personnel, and then 
exported to STATA v.13 software (Stata corp., College 
Station, TX) for analyses. Continuous variables were 
summarized by their median and inter-quartile range 
(IQR) and categorical variables as crude counts and per-
centages. We estimated the crude, unweighted preva-
lence of proteinuria and other CKD co-morbidities with 
95 % confidence intervals (CI). We used generalized lin-
ear models with a log link to report prevalence ratios (PR) 
and explore associations between proteinuria, hyperten-
sion, obesity, impaired fasting glucose, and socio demo-
graphic and lifestyle characteristics. A p value of <0.05 
was considered statistically significant.
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A secondary interest of the study was to identify high 
risk groups in the community. We estimated the poten-
tial benefit of screening among these high risk groups as 
the number needed to screen (NNS) in order to identify 
one case of proteinuria, which was defined as the recip-
rocal of the absolute risk reduction [13]. Using Bender’s 
method, we constructed a 95 % CI around the NNS esti-
mates [14]. Confidence intervals were truncated at zero.
Results
Characteristics of study participants
We enrolled 141 adults, most of whom were female 
(n =  81; 57  %), 18–39  years of age (n =  87; 64  %), and 
had a professional occupation (n  =  71; 52  %). Fewer 
than half reported a history of alcohol intake (n  =  54; 
39  %), and only two (1  %) reported a history of smok-
ing. Few respondents had a self-reported medical history 
of hypertension (n = 21; 15 %), diabetes (n = 8; 6 %), or 
heart disease (n = 4; 3 %) (Table 1). These demographics 
were similar to the population of Kampala where most 
people are female (53 %) and 18–39 years of age (61 %), 
and where many people are occupied as wage earners 
(24 %), with few being unemployed (4 %) [11, 15].
The median BMI of respondents was 25.9  kg/m2 
(IQR 22.7–30.7). More than half of respondents were 
overweight (n =  83; 59 %; 95 % CI 50–67 %) and many 
(n = 42; 30 %; 95 % CI 22–37 %) were obese. The median 
SBP was 128 (IQR 120–138)  mmHg, and median DBP 
was 78 (IQR 71–85) mmHg. The prevalence of hyper-
tension was 38  % (95  % CI 31–47  %). Among partici-
pants with hypertension (n =  54), systolic hypertension 
was more prevalent (27 %; 95 % CI 20–34 %) than dias-
tolic hypertension (21 %; 95 % CI 14–27 %). The median 
random blood glucose for participants was 91 (IQR 
80–105)  mg/dl, and 19 (13  %; 95  % CI 9–20  %) partici-
pants had impaired fasting glucose. Eighteen participants 
(13 %; 95 % CI 7–19 %) had proteinuria, of whom 16 had 
proteinuria of 1+ (89  %) and 2 (11  %) had proteinuria 
≥2+ (Table 1).
The majority of participants diagnosed with medical 
conditions during the screening were not aware of hav-
ing these conditions. Of the 43 participants newly diag-
nosed with hypertension at the screening, most (n = 32; 
74 %) were unaware of having hypertension, and of the 10 
participants with impaired fasting glucose, most (n = 7; 
70 %) were unaware.
Epidemiology of proteinuria, hypertension, and impaired 
fasting glucose
Proteinuria was most prevalent among young (18–
39 years) adults (n = 14; 16 %), and it was more promi-
nent in those who reported a history of alcohol intake 
(n = 10; 32 %). It was also most prevalent among adults 
with impaired fasting glucose (n =  3; 30  %), those who 
reported a history of diabetes (n =  2; 25 %), those with 
systolic hypertension (n  =  8; 22  %), and those occu-
pied as wage earner (n =  7; 21  %) (Table  1). There was 
no significant difference in the prevalence of proteinuria 
by gender. Proteinuria was less prevalent among partici-
pants with self reported medical history of hypertension 
(n =  1; 5  %), among older adults aged 40–59  years old 
(n = 2; 4 %) or ≥60 years old (n = 0), and among adults 
with self-reported history of smoking (n  =  0) or heart 
disease (n = 0).
In univariable regression, self-reported history of 
alcohol intake (PR  =  2.44; 1.01–5.92) and younger age 
(18–39  years old) (PR  =  3.74, 0.89–15.77) were signifi-
cantly associated with proteinuria. There was no sig-
nificant association between proteinuria and impaired 
fasting glucose, hypertension, overweight, obesity, smok-
ing, gender, or occupation (Table 1). When stratified by 
age, the significant association between alcohol intake 
and proteinuria was most prominent among younger 
(18–39  years) adults (PR =  4.35, 1.49–12.70). In multi-
variable regression, the association between alcohol 
intake and proteinuria (PR =  3.92; 95 % CI 1.10–14.03) 
persisted despite adjustment for occupation, hyperten-
sion, and impaired fasting glucose.
Potential benefits of targeted screening for proteinuria
The number needed to screen in order to identify one 
case of proteinuria in this convenience sample of urban 
residents in Kampala was eight among young (18–
39 years old) adults, six among young (18–39 years old) 
adults who were occupied as professionals, and four 
among young (18–39  years old) adults who had hyper-
tension. Among adults who report a history of alcohol 
intake, the number needed to screen to identify one case 
of proteinuria was eight across all age groups, and four 
among young (18–39 years) adults.
Discussion
Our pilot study is one of the first to assess kidney func-
tion, fasting glucose impairment, hypertension, and obe-
sity in a community setting in Uganda. The prevalence of 
proteinuria was high in this study population, and it was 
most prevalent among younger participants. Concurrent 
with this high prevalence was low disease awareness for 
hypertension and impaired fasting glucose.
Although non-communicable diseases (NCDs) such 
as diabetes and hypertension account for most cases of 
CKD in high-income countries [1], many recent stud-
ies in low- and middle-income countries (LMICs) have 
shown that CKD may only be partly attributable to these 
NCDs [6]. Other potential etiologies for CKD in LMICs 
include herbal medicines, environmental toxins, such as 
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heavy metals and agrochemicals, as well as many other 
unmeasured factors [1, 6, 7, 16]. Our findings are consist-
ent with these observations, and they highlight a need 
to explore potential etiologies of CKD, e.g., the role that 
alcohol or other environmental toxins may play in the 
development of proteinuria among young adults.
In LMICs, CKD affects younger portions of the popula-
tion which reflects the different population demographics 
observed in these countries [1, 7, 8]. Our study, which found 
a significantly higher prevalence among younger age groups, 
highlights the urgent need for epidemiologic studies capa-
ble of identifying high-risk populations. Proteinuria is an 
important predictor of risk of progression to end-stage renal 
disease as well as cardiovascular disease [17–19]. As such, 
understanding its epidemiology, especially if it dispropor-
tionately affects younger, economically productive adults, is 
critically important in developing public health agendas in 
Uganda. Moreover, because of the limited availability and 
readiness of the health system in Uganda to care for chronic 
diseases such as CKD [20], screening for proteinuria, which 
is an efficient, reliable, and easily obtainable means of 
assessing kidney function, may be an effective strategy, par-
ticularly in lower level health facilities where other kidney 
function measurements are not available [21–23].
In response to the need for increasing awareness and 
screening for NCDs such as CKD, the Uganda Kidney 
Foundation has used various platforms and strategies 
to engage key stakeholders, such as physicians, nurses, 
Table 1 Characteristics of participants by proteinuria status (n = 141), Kampala, Uganda; 2013
PR prevalence ratio
a Co-variates: gender, occupation, hypertension, impaired fasting glucose
b Wage earner: any non-salaried position (e.g., construction worker, farmer)
c Professional: any salaried position (e.g. nurse, teacher, government employee)














 18–39 years old 87 14 (16 %) 72 (84 %) 3.74 (0.89–15.77) 7.96 (1.39–45.44)
 40–59 years old 46 2 (4 %) 44 (96 %) Ref Ref
 ≥60 years old 4 0 4 (100 %) – –
Gender
 Male 60 9 (15 %) 50 (85 %) 1.36 (0.57–3.21) –
 Female 81 9 (11 %) 71 (89 %) Ref –
Occupation
 Unemployed 6 1 (17 %) 5 (83 %) Ref –
 Student 27 2 (7 %) 25 (93 %) – –
 Wage earnerb 33 7 (21 %) 26 (79 %) 1.35 (0.30–6.10) –
 Professionalc 71 7 (10 %) 63 (90 %) 2.25 (0.24–20.96) –
History of Smoking 2 0 2 (100 %) – –
History of alcohol intake 54 11 (20 %) 43 (80 %) 2.44 (1.01–5.92) 3.92 (1.10–14.03)
 18–39 years old 31 10 (32 %) 21 (68 %) 4.35 (1.49–12.7) –
 40–59 years old 20 1 (5 %) 19 (95 %) 1.30 (0.09–19.5) –
 >60 years old 2 0 2 (100 %) – –
Self-reported medical history
 Hypertension 21 1 (5 %) 20 (95 %) – –
 Diabetes mellitus 8 2 (25 %) 6 (75 %) – –
 Heart diseased 4 0 4 (100 %) – –
Body mass index
 Normal weight 58 8 (14 %) 50 (86 %) Ref –
 Overweight 81 10 (12 %) 71 (88 %) 1.24 (0.49–3.14) –
 Obese 40 3 (8 %) 37 (92 %) 0.54 (0.15–1.93) –
Hypertension 54 9 (17 %) 45 (83 %) 1.57 (0.67–3.71) 1.50 (0.41–5.83)
 Systolic hypertension 38 8 (21 %) 30 (79 %) 2.13 (0.91–4.98) –
 Diastolic hypertension 29 5 (17 %) 24 (83 %) 1.46 (0.57–3.76) –
 Impaired fasting glucose 19 5 (26 %) 14 (74 %) 2.43 (0.98–6.04) 1.64 (0.28–9.73)
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medical officers, and public health officials in the Min-
istry of Health. The Uganda Kidney Foundation also 
partnered with professional societies including the Inter-
national Society of Nephrology (ISN) to organize the first 
international kidney conference in Kampala in 2012 to 
increase awareness and care for kidney disease among 
clinicians [24]. Because CKD often goes undetected, col-
laborative efforts to increase awareness and to screen at-
risk community members may be the most effective and 
cost-efficient public health strategies to address the bur-
den of CKD, particularly in a LMIC like Uganda [25–29].
Our study has many strengths. The screening activ-
ity was carried out by internal medicine residents at 
MakCHS, who obtained relevant medical history from 
respondents during the screening to exclude data from 
respondents with proteinuria secondary to other medical 
conditions, such as urinary tract infections (UTIs). Addi-
tionally, with limited resources, we were able to screen 
for proteinuria, hypertension, impaired fasting glucose, 
and obesity using standard definitions and diagnostic 
tests.
Despite these strengths, we noted several limitations. 
Because urine dipstick measurements for proteinuria 
can be non-specific, we could not exclude orthostatic or 
transient proteinuria, or evaluate for possible glomerulo-
nephritis, and we did not repeat the proteinuria assess-
ment. Additionally, we did not assess kidney function 
using serum creatinine and estimated glomerular filtra-
tion rate, and the cross-sectional design prevents any 
causal assumptions about etiologies. For example, the 
association between alcohol intake and proteinuria that 
we observed could be due to unmeasured confounding 
effects. Because we obtained a convenience sample of 
people who attended the World Kidney Day celebrations 
in Kampala, our prevalence estimates are not generaliz-
able to the Kampala urban population. As such, our con-
fidence intervals are intended to measure the variance of 
the observed sample, and not the underlying Kampala 
general population. Selection bias was also a concern. 
Health-conscious individuals were more likely to partici-
pate in screening activities than the general population. 
Nonetheless, our pilot findings highlight the urgent need 
for and feasibility of future epidemiological studies per-
taining to CKD and other NCDs in Uganda.
Conclusions
We observed a high prevalence of proteinuria in a con-
venience sample of urban residents in a sub-Saharan 
African setting. These results are among the first to be 
reported for a community-based sample in Uganda, and 
they represent an important effort by the Uganda Kid-
ney Foundation to increase awareness and recognition 
of CKD. These estimates will help formulate additional 
epidemiological studies on NCDs in Uganda which are 
urgently needed.
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